ClinVar Miner

Submissions for variant NM_000059.4(BRCA2):c.4270dup (p.Ser1424fs)

dbSNP: rs1555283672
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000588475 SCV000694760 likely pathogenic Hereditary breast ovarian cancer syndrome 2016-08-11 criteria provided, single submitter clinical testing Variant summary: The BRCA2 c.4270dupT (p.Ser1424Phefs) variant results in a premature termination codon, predicted to cause a truncated or absent BRCA2 protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (e.g.c.1310_1313delAAGA/p.Lys437fs). One in silico tool predicts a damaging outcome for this variant. This variant is absent in 119534 control chromosomes. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories; nor evaluated for functional impact by in vivo/vitro studies. Taken together, this variant is classified as likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.